Open research questions in Thyroid Cancer Diagnosis and Treatment
249 unresolved questions extracted from the limitations and future-work sections of 651 Thyroid Cancer Diagnosis and Treatment papers in our library. Each links back to the study that raised it.
What the literature leaves open
1. Further research with larger, multicenter cohorts should be undertaken to validate these findings, assess performance across diverse populations, and explore to improve specificity. integration with molecular testing
APPLICATION OF BETHESDA SYSTEM IN CYTOLOGICAL EVALUATION AND CORRELATION TO HISTOPATHOLOGY OF SOLITARY THYROID NODULE · 2026 · DOIInvestigate the independent effects of fixative type and storage duration on assay performance, - Examine the relationship between turnaround time and assay choice
Optimizing Tissue Preparation for Molecular Testing in Thyroid Tumors: A Retrospective Analysis of 177 Cases from a High-Volume Japanese Center · 2026 · DOIthe pathophysiology of thyroidectomized patients is complex and influenced by multiple factors - individual variations in the HPT axis may not be fully reflected in standard thyroid function tests - the effectiveness of soft gel LT4 has been investigated in a limited number of clinical studies
Levothyroxine therapy in thyroidectomized patients: ongoing challenges and controversies · 2025 · DOIevaluating the impact of levothyroxine therapy on quality of life is an area of growing interest in patient-centered outcomes research - assessing the quality of life in patients who had undergone thyroidectomy in relation to thyroid hormone replacement therapy - investigating the effects of TSH suppression therapy on bone health
Levothyroxine therapy in thyroidectomized patients: ongoing challenges and controversies · 2025 · DOIThe current epidemiological data on ATC remain outdated, with available statistics extending only through 2015 or earlier. The study is based on a retrospective analysis of the SEER database and may have limitations related to data quality and completeness. The study does not provide information on the causes of the increasing incidence and mortality of ATC.
Trends in incidence, mortality, and conditional survival of anaplastic thyroid cancer over the last two decades in the USA · 2025 · DOIFurther studies are needed to investigate the causes of the increasing incidence and mortality of ATC. Research on the development of new treatments and therapies for ATC is necessary. Studies on the validation of the CS-nomogram in other populations and datasets are required.
Trends in incidence, mortality, and conditional survival of anaplastic thyroid cancer over the last two decades in the USA · 2025 · DOIThe study had a retrospective design, - The sample size was limited to 47 patients, - The study was conducted at a single tertiary thyroid center
Ultrasound and histopathological assessment of benign, borderline, and malignant thyroid tumors in pediatric patients: an illustrative review and literature overview · 2025 · DOIFurther studies are needed to clarify the distinguishing characteristics of borderline lesions, - Research should focus on the effective differentiation of borderline lesions from other thyroid pathologies, - Studies should investigate the indolent biological behavior of NIFTP
Ultrasound and histopathological assessment of benign, borderline, and malignant thyroid tumors in pediatric patients: an illustrative review and literature overview · 2025 · DOIBACKGROUND: Growing evidence suggests a complex interplay between thyroid function and various cancers, and yet their shared genetic basis and underlying mechanisms remain unclear.
Importance: The magnitude of thyroid cancer overdiagnosis in the US, accounting for the true increase in underlying disease, has not been quantified.
Background: Xenotropic and polytropic retrovirus receptor 1 (XPR1) is highly expressed in human thyroid carcinoma (TC), yet its functional role remains unclear.
XPR1 Promotes the Malignant Phenotypes of Thyroid Carcinoma Cells Partly Through NF-κB-Related Signaling · 2026 · DOIHowever, its epidemiological investigation including the disease burden and its trends remains insufficiently explored.
Global trend and disparity in the burden of thyroid cancer attributable to high body-mass index from 1990 to 2021 and projection to 2049: a systematic analysis based on the Global Burden of Disease Study 2021 · 2025 · DOIDespite their prevalence, the psychological impact of thyroid nodules remains underexplored.
Anxiety disorders in patients with thyroid nodules vs. thyroid cancer: a retrospective cohort study · 2025 · DOIPurpose: While the prognosis for differentiated thyroid cancer (DTC) is favorable, the health-related quality of life (QOL) of survivors is not well understood.
Factors influencing the quality of life in survivors of differentiated thyroid cancer based on patient-reported outcomes: a single-center cross-sectional study · 2025 · DOIHowever, the specific molecular mechanisms involved in PTC evolution, driven by metabolic reprogramming and tumor-microenvironmental interactions, remain poorly understood.
Integrated spatial metabolomics and transcriptomics reveal the molecular landscape of papillary thyroid cancer and its lymph node metastasis · 2025 · DOIGastrointestinal metastases are rare in patients with thyroid carcinoma (TC), and their underlying mechanisms remain unclear.
Analysis of thyroid carcinoma composition and spatial architecture in the progression of dedifferentiation, lymphatic metastasis, and gastric metastasis · 2025 · DOIWith increasing incidental identification of these variants in asymptomatic individuals outside family screening, these individuals' risk of medullary thyroid cancer and all-cause mortality without intervention remain unknown in this context.
Medullary Thyroid Cancer Risk and Mortality in Carriers of Incidentally Identified MEN2A RET Variants · 2025 · DOICompared with the clinical assessment and diagnosis of thyroid nodules, there are relatively few studies on the epidemiological risk factors for thyroid nodules.
Prevalence of thyroid nodule and relationship with physiological and psychosocial factors among adults in Zhejiang Province, China: a baseline survey of a cohort study · 2024 · DOISimilarly, few studies have investigated the interactions between hormones and hormone systems.
A review of complex hormone regulation in thyroid cancer: novel insights beyond the hypothalamus–pituitary–thyroid axis · 2024 · DOIIn fact, numerous studies of patients with acromegaly have shown that serum levels of GH and insulin-like growth factor-1 (IGF-1) may be associated with the onset and progression of TC, although the influences of age, sex, and other risk factors, such as obesity and stress, remain unclear.
A review of complex hormone regulation in thyroid cancer: novel insights beyond the hypothalamus–pituitary–thyroid axis · 2024 · DOITherefore, in cases where the initial FNA diagnosis of thyroid nodules is inconclusive, CNB should be considered as a viable option for re-puncture.
A comparative analysis of core needle biopsy and repeat fine needle aspiration in patients with inconclusive initial cytology of thyroid nodules · 2024 · DOIAs the degree and speed of lesion absorption vary greatly between individuals, an effective model to predict curative effect after ablation is lacking.
A prognostic model for thermal ablation of benign thyroid nodules based on interpretable machine learning · 2024 · DOIBackground Previous observational studies have shown conflicting results of vitamins supplementation for thyroid diseases.
Association of circulating vitamin levels with thyroid diseases: a Mendelian randomization study · 2024 · DOIAs the pathogenic mechanisms of RAIR-DTC remain elusive, here we aim to review recent advances in understanding the pathogenesis of RAIR-DTC and provide valuable insights for the development of future molecularly targeted therapeutic approaches.
Pathogenesis and signaling pathways related to iodine-refractory differentiated thyroid cancer · 2024 · DOIBackground There is currently insufficient data to validate adult-based US risk stratification systems (RSSs) for the identification of malignant thyroid nodules in a pediatric population.
Most-cited papers in Thyroid Cancer Diagnosis and Treatment
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002 · JAMA · 2006 · 2,750 citations
- Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013 · JAMA · 2017 · 1,863 citations
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer · New England Journal of Medicine · 2015 · 1,841 citations
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial · The Lancet · 2014 · 1,442 citations
- Overview of the 2022 WHO Classification of Thyroid Neoplasms · Endocrine Pathology · 2022 · 1,104 citations
- Thyroid Incidentalomas · Archives of Internal Medicine · 1994 · 751 citations
- The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020 · The Lancet Diabetes & Endocrinology · 2022 · 650 citations
- Thyroid Cancer · JAMA · 2024 · 591 citations
- Treatment Guidelines for Patients With Thyroid Nodules and Well-Differentiated Thyroid Cancer · Archives of Internal Medicine · 1996 · 439 citations
- Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study · Annals of Oncology · 2022 · 350 citations
Most recent work
- Overdiagnosis of Papillary Thyroid Cancer · JAMA Network Open · 2026
- Lymphatic metastasis of papillary thyroid carcinoma: mechanism and clinicopathological physiology · Frontiers in Endocrinology · 2026
- Systemic Treatment of Thyroid Cancer: ASCO Guideline · Journal of Clinical Oncology · 2026
- Neoadjuvant Combination Therapy with Tyrosine Kinase and Immune Checkpoint Inhibitors in Anaplastic Thyroid Cancer: A Single-Center, Real-World Experience · Annals of Surgical Oncology · 2026
- A Novel Approach to Targeting DLL3 with Tarlatamab in a Patient with Medullary Thyroid Carcinoma after Progression on Selpercatinib · Thyroid® · 2026
- Letter to the Editor: Enhancing Node-RADS for preoperative assessment of cervical lymph node metastases in papillary thyroid carcinoma: a focused question on patient-level decision-making · European Radiology · 2026
- Letter to the Editor: Microflow imaging for ultrasound risk stratification of thyroid nodules: potential roles and key considerations · European Radiology · 2026
- ZEB1 level in thyroid papillary carcinoma tissue, metastasis, blood mononuclear cells and plasma · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · 2026
- A clinically anchored radiomics dictionary for explainable TI-RADS–based thyroid nodule classification in ultrasound; dictionary version TU1.0 · European Journal of Radiology · 2026
- Association of common genetic alterations with tumor recurrence in papillary thyroid cancer · JNCI: Journal of the National Cancer Institute · 2026
Find a gap in your own Thyroid Cancer Diagnosis and Treatment sub-topic
This page shows what the Thyroid Cancer Diagnosis and Treatment literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →